SCHEMBL13941982

SCHEMBL13941982

CC(C)[Si](C)(C)CCCO

nearest known ligand 0.32

Predicted protein targets (top 2)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 1/20 0.32
SMN1; SMN2 Q16637 1/20 0.30

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL505851 0.82
SCHEMBL2960790 0.76 ALDH1A1 (0.30) ALDH1A1
SCHEMBL14865953 0.75
SCHEMBL16602995 0.74 TSHR (0.33)
SCHEMBL10519281 0.69 ALDH1A1 (0.39) ALDH1A1SMN1; SMN2
SCHEMBL13941987 0.69
SCHEMBL402873 0.69
SCHEMBL10397542 0.67 ALDH1A1 (0.37) ALDH1A1SMN1; SMN2
SCHEMBL12879482 0.67
SCHEMBL28033411 0.67

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-9505790-B2 Silane compounds and their use in functionalizing solid supports and immobilizing biological molecules on these supports COMMISSARIAT A L'ENERGIE ATOMIQUE (FR) 2016-11-29 US disclosed
US-20090005269-A1 Novel Silane Compounds and Their Use in Functionalizing Solid Supports and Immobilizing Biological Molecules on These Supports CENTRE NATIONAL DE LA RECHERCHE SCIENTIFIQUE (FR) 2009-01-01 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20090005269-A1 Novel Silane Compounds and Their Use in Functionalizing Solid Supports and Immobilizing Biological Molecules on These Supports SELE, ELANE, EPCAM ALDH1A1 374/4885SMN1; SMN2 4295/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.